Compare SMBK & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SMBK | MLAB |
|---|---|---|
| Founded | N/A | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 893.2M | 719.9M |
| IPO Year | 2000 | 1995 |
| Metric | SMBK | MLAB |
|---|---|---|
| Price | $49.86 | $129.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $52.71 | ★ $117.50 |
| AVG Volume (30 Days) | 83.0K | ★ 93.8K |
| Earning Date | 10-20-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.73% | 0.49% |
| EPS Growth | 39.25 | ★ 436.11 |
| EPS | ★ 1.77 | 0.49 |
| Revenue | N/A | N/A |
| Revenue This Year | $12.63 | $2.48 |
| Revenue Next Year | $9.31 | $5.86 |
| P/E Ratio | ★ $27.99 | $270.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.01 | $66.56 |
| 52 Week High | $54.14 | $138.66 |
| Indicator | SMBK | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 37.51 | 54.76 |
| Support Level | $40.28 | $94.20 |
| Resistance Level | $53.03 | $132.70 |
| Average True Range (ATR) | 1.03 | 4.49 |
| MACD | -0.26 | -0.64 |
| Stochastic Oscillator | 17.66 | 51.84 |
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.